Targeting MEK in vemurafenib-resistant hairy cell leukemia

Leukemia. 2019 Feb;33(2):541-545. doi: 10.1038/s41375-018-0270-2. Epub 2018 Oct 19.

Rebecca Caeser^#^{1

2}, Grace Collord^#^{3

4}, Wen-Qing Yao⁵, Zi Chen⁵, George S Vassiliou^{1

3}, Philip A Beer³, Ming-Qing Du⁵, Mike A Scott⁶, George A Follows⁷, Daniel J Hodson^{8

9

10}

¹ Department of Haematology, University of Cambridge, Cambridge, UK.
² Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK.
³ Wellcome Sanger Institute, Hinxton, UK.
⁴ Department of Paediatrics, University of Cambridge, Cambridge, UK.
⁵ Division of Molecular Histopathology, University of Cambridge, Cambridge, UK.
⁶ Haematopathology & Oncology Diagnostic Service, Cambridge University Hospitals, Cambridge, UK.
⁷ Department of Haematology, Cambridge University Hospitals, Cambridge, UK.
⁸ Department of Haematology, University of Cambridge, Cambridge, UK. djh1002@cam.ac.uk.
⁹ Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK. djh1002@cam.ac.uk.
¹⁰ Department of Haematology, Cambridge University Hospitals, Cambridge, UK. djh1002@cam.ac.uk.

^# Contributed equally.

No abstract available

Publication types